US › Healthcare

Medicus Pharma Ltd. Common Stock (MDCX)

US · Healthcare · Drug Manufacturers - General

$0.17+9.22%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-8.4M

EPS

$-0.21

EPS estimate

$-0.14

EPS came in at -0.21 against a street estimate of -0.14 — a miss of 50.0%.

Key statistics

Market cap

$10.1M

Forward P/E

0.0

P/B

11.97

Book value

$-0.03

EPS (TTM)

$-2.36

52-week high

$3.05

52-week low

$0.14

50-day MA

$0.30

200-day MA

$0.73

Beta

-0.48

Analyst view

with an average price target of $4.47.

Shareholding

Insiders

11.19%

Institutions

4.15%

Largest institutional holders

Fund	Stake
Interchange Capital Partners, LLC	2.51%
Virtu Financial LLC	0.12%
Commonwealth Equity Services, LLC	0.08%
Bryn Mawr Trust Company	0.08%
May Hill Capital, LLC	0.08%
UBS Group AG	0.06%
BlackRock Inc	0.06%
Stratos Wealth Partners, LTD	0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Medicus Pharma Ltd. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.